AmendmentAmendment • May 15th, 2024 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledMay 15th, 2024 Company IndustryThis Amendment (this “Amendment”), dated as of [ ], 2024, is by and among MyMD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the investors listed on the signature pages attached hereto (the “Investors”).